SCHEMBL23937116

SCHEMBL23937116

c1ccc(-c2cc(-n3c4ccccc4c4c5c6ccccc6n(-c6ccc7oc8ccccc8c7c6)c5ccc43)ccn2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
NPC1 O15118 2/20 0.36
COMT P21964 1/20 0.34
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ASIC3 Q9UHC3 1/20 0.33
LMNA P02545 1/20 0.32
PIM1 P11309 1/20 0.32
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PRKDC P78527 1/20 0.31
AHR P35869 1/20 0.31
MAPK1 P28482 1/20 0.30
PTK2B Q14289 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17809341 0.89 MAPT (0.35) MAPTNPC1KMT2AKDM4EMEN1
SCHEMBL23937115 0.85 L3MBTL1 (0.45) MAPTNPC1COMTKMT2AKDM4E
SCHEMBL18125601 0.85 KDM4E (0.40) MAPTNPC1KMT2AKDM4EMEN1
SCHEMBL18615824 0.85 KDM4E (0.40) MAPTNPC1KMT2AKDM4EMEN1
SCHEMBL30103706 0.85 KDM4E (0.40) MAPTNPC1KMT2AKDM4EMEN1
SCHEMBL23805831 0.84 MAPT (0.33) MAPTNPC1KMT2AKDM4EMEN1
SCHEMBL9889811 0.84 MAPT (0.45) MAPTNPC1KMT2AKDM4EMEN1
SCHEMBL14770703 0.83 KDM4E (0.36) MAPTNPC1COMTKMT2AKDM4E
SCHEMBL23805719 0.83 MAPT (0.35) MAPTNPC1KMT2AKDM4EMEN1
SCHEMBL17809344 0.83 KMT2A (0.37) MAPTNPC1KMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323968-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323968-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ECI1, NDUFS3, NDUFV1 MAPT 1035/4885NPC1 2332/4885COMT 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.